Iovance Biotherapeutics Stock (NASDAQ: IOVA) stock price, news, charts, stock research, profile.
Open | $7.78 |
Close | $7.39 |
Volume / Avg. | 6.28M / 6.17M |
Day Range | 7.30 - 7.89 |
52 Wk Range | 3.21 - 18.33 |
Market Cap | $2.06B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 21.78% |
Days to Cover | 6.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Iovance Biotherapeutics (NASDAQ:IOVA) through any online brokerage.
Other companies in Iovance Biotherapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX) and Agios Pharmaceuticals (NASDAQ:AGIO).
There is no analysis for Iovance Biotherapeutics.
Iovance Biotherapeutics has a consensus price target of $20.71.
The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $7.3793 last updated July 3, 2024 at 4:58 PM EDT.
There are no upcoming dividends for Iovance Biotherapeutics.
Iovance Biotherapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Iovance Biotherapeutics.
Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.